TASP1

taspase 1

Basic information

Region (hg38): 20:13389392-13638932

Previous symbols: [ "C20orf13" ]

Links

ENSG00000089123NCBI:55617OMIM:608270HGNC:15859Uniprot:Q9H6P5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Suleiman-El-Hattab syndrome (Moderate), mode of inheritance: AR
  • Suleiman-El-Hattab syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Suleiman-El-Hattab syndromeARAllergy/Immunology/Infectious; CardiovascularAmong other features, individuals have been described with recurrent respiratory infections, and awareness may allow management of these sequelae; The condition can involve congenital cardiac anomalies, and awareness may allow early managementAllergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic31209944

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TASP1 gene.

  • Global developmental delay (1 variants)
  • Suleiman-El-Hattab syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TASP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
1
clinvar
16
clinvar
2
clinvar
19
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
3
6
9
non coding
1
clinvar
1
Total 1 3 17 4 2

Variants in TASP1

This is a list of pathogenic ClinVar variants found in the TASP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-13390425-C-T Inborn genetic diseases Uncertain significance (Oct 25, 2022)2396084
20-13390451-G-C Inborn genetic diseases Uncertain significance (Feb 15, 2023)2466281
20-13390456-CAG-C TASP1-related disorder Likely benign (Dec 16, 2019)3055272
20-13417495-C-T Inborn genetic diseases Uncertain significance (Dec 06, 2021)2265152
20-13435077-G-T Inborn genetic diseases Uncertain significance (Jun 28, 2023)2607130
20-13435080-C-T Inborn genetic diseases Uncertain significance (Aug 10, 2021)2242392
20-13435113-C-T Uncertain significance (Jul 28, 2020)973975
20-13435116-C-T Suleiman-El-Hattab syndrome Uncertain significance (Apr 26, 2024)3256687
20-13483235-T-C Suleiman-El-Hattab syndrome Uncertain significance (Jan 31, 2022)1683690
20-13483309-T-C Inborn genetic diseases Uncertain significance (Jul 13, 2021)2231960
20-13483347-C-T Suleiman-El-Hattab syndrome Uncertain significance (Feb 22, 2022)2442162
20-13534015-T-C TASP1-related disorder Benign (Jan 27, 2020)3043220
20-13534052-C-T TASP1-related disorder Benign (Nov 12, 2019)3033137
20-13534091-G-A Likely benign (Aug 01, 2022)2652206
20-13534116-G-A Abnormal facial shape;Happy demeanor;Global developmental delay • Suleiman-El-Hattab syndrome Likely pathogenic (Mar 14, 2024)633774
20-13534126-T-C Inborn genetic diseases Uncertain significance (Oct 25, 2022)2319503
20-13559007-C-A Suleiman-El-Hattab syndrome Likely pathogenic (Dec 07, 2022)1878237
20-13559038-T-A TASP1-related disorder Likely benign (Mar 15, 2022)3032674
20-13559042-A-T TASP1-related disorder • Inborn genetic diseases Uncertain significance (Oct 10, 2023)3031881
20-13559094-T-C Inborn genetic diseases Uncertain significance (Apr 01, 2024)3324541
20-13569512-G-A Inborn genetic diseases Uncertain significance (Aug 12, 2022)2399221
20-13569524-G-A Inborn genetic diseases Uncertain significance (May 01, 2024)3324542
20-13569567-C-T Suleiman-El-Hattab syndrome Uncertain significance (Jan 18, 2023)2436955
20-13580926-G-A Suleiman-El-Hattab syndrome Uncertain significance (Apr 26, 2024)3256682
20-13580983-T-C Suleiman-El-Hattab syndrome Likely pathogenic (Jan 16, 2023)1992428

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TASP1protein_codingprotein_codingENST00000337743 13372879
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6080.3921257320101257420.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.581592260.7040.00001142689
Missense in Polyphen2571.4040.35012771
Synonymous-0.1338886.41.020.00000511827
Loss of Function3.68524.80.2020.00000124317

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009490.0000907
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00009260.0000924
European (Non-Finnish)0.00004470.0000440
Middle Eastern0.000.00
South Asian0.00003580.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Protease involved in KMT2A/MLL1 processing and, consequently, in the correct expression of the early HOXA gene cluster. {ECO:0000269|PubMed:14636557}.;

Recessive Scores

pRec
0.241

Intolerance Scores

loftool
0.156
rvis_EVS
-0.18
rvis_percentile_EVS
39.95

Haploinsufficiency Scores

pHI
0.213
hipred
Y
hipred_score
0.728
ghis
0.565

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.734

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tasp1
Phenotype
immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
proteolysis;positive regulation of transcription, DNA-templated;protein maturation
Cellular component
cytoplasm
Molecular function
threonine-type endopeptidase activity;hydrolase activity;identical protein binding